Design of a phase 3, international, prospective, randomized, double-blind, placebo (PBO) controlled study assessing efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in patients with well-differentiated, advanced typical and atypical lung NETs Meeting Abstract
| Authors: | Reidy-Lagunes, D.; Kulke, M.; Wolin, E.; Mirakhur, B.; Massien, C.; Caplin, M.; Baudin, E. |
| Abstract Title: | Design of a phase 3, international, prospective, randomized, double-blind, placebo (PBO) controlled study assessing efficacy and safety of lanreotide autogel/depot (LAN) 120 mg in patients with well-differentiated, advanced typical and atypical lung NETs |
| Meeting Title: | 13th Annual European Neuroendocrine Tumor Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease |
| Keywords: | lanreotide; lung nets |
| Journal Title: | Neuroendocrinology |
| Volume: | 103 |
| Issue: | Suppl. |
| Meeting Dates: | 2016 Mar 9-11 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0028-3835 |
| Publisher: | S. Karger AG |
| Date Published: | 2016-10-01 |
| Start Page: | 118 |
| Language: | English |
| ACCESSION: | WOS:000386481600308 |
| PROVIDER: | wos |
| PUBMED: | 27710961 |
| DOI: | 10.1159/000448725 |
| Notes: | Meeting Abstract: R11 -- Source: Wos |
